Patients who received a faulty BioMet M2a Magnum hip replacement are eligible to participate in a recently announced settlement, as long as they file their lawsuit prior to April 15th. BioMet has agreed to settle lawsuits for a minimum of $56 million.
Biomet Inc. reached the settlement after hundreds of hip implant lawsuits were consolidated in a multi-district litigation in Indiana. The settlement includes a base pay of $200,000 per individual. Patients must sue the company in federal court before April 15th to participate in the settlement, though it is also possible for patients who suffered hip replacement injuries to file a lawsuit against the company separately.
The BioMet M2a Magnum hip replacement was found to cause severe side effects shortly after approval, including tissue damage, limited mobility and toxic levels of metal in the bloodstream. Despite the settlement, the company never issued an M2a Magnum recall for the faulty hip devices.